STOCK TITAN

LeonaBio: Spruce Street reports 4.2% shared stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

LeonaBio, Inc. (LONA) is the issuer named in a Schedule 13G reporting shared beneficial ownership of 393,700 common shares, or 4.2%, by Spruce Street Capital LP, Alex R. Rosen and Simon Basseyn. The filing says 9,421,663 common shares were outstanding as of August 12, 2026, the basis cited for the 4.2% figure. As of September 30, 2026, the reporting persons may have been deemed to beneficially own 1,033,464 shares, including 639,763 shares issuable under warrants. The warrants were subject to a 9.99% exercise blocker and expired unexercised on October 18, 2026. Spruce Street Capital Master Fund LP was identified as having the right to receive or direct dividends or sale proceeds from more than 5% of outstanding shares as of September 30, 2026.

Shared beneficial ownership 393,700 shares Reported by each reporting person; 4.2% of the class.
Reported ownership percentage 4.2% Based on 9,421,663 common shares outstanding as of August 12, 2026.
Potential beneficial ownership 1,033,464 shares As of September 30, 2026; the reporting persons may have been deemed to own this amount, including 639,763 shares issuable upon warrant exercise.
Warrant shares 639,763 shares Issuable upon exercise of warrants that expired unexercised on October 18, 2026.
Warrant exercise blocker 9.99% Warrants were not exercisable to the extent exercise would result in beneficial ownership above this level.
Shares outstanding 9,421,663 shares As of August 12, 2026; basis cited for the reported 4.2% ownership percentage.
beneficial ownership regulatory
"may have been deemed to beneficially own 1,033,464 shares"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
9.99% blocker regulatory
"Warrants described on the cover pages were subject to a 9.99% blocker"
Warrants financial
"639,763 shares of Common Stock issuable upon exercise of warrants"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many LONA shares did Spruce Street Capital report?

Spruce Street Capital LP, Alex R. Rosen and Simon Basseyn each reported shared voting and dispositive power over 393,700 LeonaBio common shares, representing 4.2% of the class. Each reporting person's cover page reports the same shared position.

How many warrant shares were included in the September 30, 2026 LONA ownership disclosure?

The reporting persons may have been deemed to beneficially own 1,033,464 shares, including 639,763 shares issuable upon warrant exercise. The warrants were subject to a 9.99% blocker and expired unexercised on October 18, 2026.

Which fund had dividend or sale-proceeds rights in LONA?

Spruce Street Capital Master Fund LP, a Spruce Street Fund, had the right to receive or direct dividends or proceeds from the sale of more than 5% of LeonaBio's outstanding common shares as of September 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





04746L203

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The information set forth on this cover page reflects information as of the date hereof. As of September 30, 2026, the Reporting Persons may have been deemed to beneficially owned 1,033,464 shares of Common Stock (as defined below), including 639,763 shares of Common Stock issuable upon exercise of warrants (the "Warrants"). On October 18, 2026, the Warrants expired unexercised.


SCHEDULE 13G




Comment for Type of Reporting Person: The information set forth on this cover page reflects information as of the date hereof. As of September 30, 2026, the Reporting Persons may have been deemed to beneficially owned 1,033,464 shares of Common Stock, including 639,763 shares of Common Stock issuable upon exercise of warrants (the "Warrants"). On October 18, 2026, the Warrants expired unexercised.


SCHEDULE 13G




Comment for Type of Reporting Person: The information set forth on this cover page reflects information as of the date hereof. As of September 30, 2026, the Reporting Persons may have been deemed to beneficially owned 1,033,464 shares of Common Stock, including 639,763 shares of Common Stock issuable upon exercise of warrants (the "Warrants"). On October 18, 2026, the Warrants expired unexercised.


SCHEDULE 13G



Spruce Street Capital LP
Signature:/s/ Alex R. Rosen
Name/Title:Spruce Street Capital GP LLC, its General Partner, By: Alex R. Rosen, its Co-Managing Member
Date:11/13/2026
Alex R. Rosen
Signature:/s/ Alex R. Rosen
Name/Title:Alex R. Rosen, individually
Date:11/13/2026
Simon Basseyn
Signature:/s/ Simon Basseyn
Name/Title:Simon Basseyn, individually
Date:11/13/2026
Exhibit Information

Exhibit 99.1: Joint Filing Agreement

Keep reading